Woodcast was awarded in the New tree 2014 competition

Woodcast casting material made from pure wood and biodegradable plastic is a winner in the series Demograhpic changes of New tree 2014 competition.

The jury assessed Woodcast as follows:

“In this concept interesting is the new context of use of wood as a casting material and, above all, the user-oriented development. The identification of needs of various different user groups is a good place to start developing next prototypes of this product.”
“Innovative. Recyclability good.”
“Very creative solution to the basic process of everyday health care. The operational characteristics allow flexible use of the product.”

(more…)

Read More

Herantis Pharma has initiated Phase 2 study with Cis-UCA Eye Drops in Patients with Dry Eye Syndrome, results expected in Q3/2015

Herantis Pharma has initiated Phase 2 study with Cis-UCA Eye Drops in Patients with Dry Eye Syndrome, results expected in Q3/2015

Herantis Pharma Plc.
Company release 7 January 2015 at 9:00 am

Herantis Pharma Plc. has initiated its Phase 2 clinical study with Cis-UCA Eye Drops in patients with Dry Eye Syndrome. In the study, 150 patients with Dry Eye Syndrome will be randomized to receive 4 weeks of treatment with either placebo eye drops or two different strengths of cis-UCA Eye Drops. The objective of the study is to compare the safety and efficacy of Cis-UCA Eye Drops to placebo, for the treatment of the signs and symptoms of Dry Eye Syndrome.

(more…)

Read More

Herantis Pharma announces FDA clearance of IND for Phase 2 study of Cis-UCA Eye Drops

Herantis Pharma announces FDA clearance of IND for Phase 2 study of Cis-UCA Eye Drops

Herantis Pharma plc.
Company release 8 September 2014 at 8:30 a.m.

The United States Food and Drug Administration (FDA) has cleared the Investigational New Drug application (IND) of Herantis Pharma Plc. for a Phase 2 clinical study of Cis-UCA Eye Drops for the treatment of Dry Eye Syndrome. Patient enrolment in the clinical study is planned to start by the end of 2014.

(more…)

Read More